About the Company
Tyme Technologies, Inc., is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company's therapeutic approach is designed to take advantage of a cancer cell's innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body's natural immune system. With the development of TYME-18 and TYME-19, the Company believes that it is also emerging as a leader in the development of bile acids as potential therapies for cancer and COVID-19.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TYME News
Tyme Technologies (NASDAQ: TYME)
TYME Inc. is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have tolerable toxicity profiles. Unlike targeted ...
A Trickster Enters the Fight Against Metastatic Cancers
Del Priore quit his day job at one of the largest cancer treatment organizations in the United States and joined TYME Technologies Inc., an emerging biotechnology company and the innovator of SM-88.
EGRX Eagle Pharmaceuticals, Inc.
It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was ...
Richard Anthony Cunningham,'s Net Worth
This is based on reported shares across multiple companies, which include TYME TECHNOLOGIES, INC., Icagen, Inc., and Anebulo Pharmaceuticals, Inc.. Attention insiders: Dive deeper into market ...
RBT Rubicon Technologies, Inc.
Rubicon Technologies, Inc., a digital marketplace for waste and recycling services, provides cloud-based waste and recycling solutions to businesses, governments, and organizations worldwide.
Tyler Technologies Inc TYL
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Applied Industrial Technologies Inc.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
SilverSun Technologies, Inc. (SSNT)
Mark Meller, CEO and 10% Owner of SilverSun Technologies Inc (NASDAQ:SSNT), has sold 14,584 shares of the company on March 25, 2024, according to a recent SEC filing. Mark Meller, CEO and 10% ...
Lumen Technologies Inc Ordinary Shares LUMN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
BioSig Technologies, Inc. (BSGM)
BAIPC will work to deploy a series of solutions to transform BioSig’s future courseWestport, CT, April 04, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the ...
Helios Technologies Inc.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Loading the latest forecasts...